Carmustine [karmustin]
- Terms
-
BCNU
BiCNU
FIVB
N,N'-di(2-chlorethyl)-N-nitrosomočovina
-
1,3-Bis(2-Chloroethyl)-1-Nitrosourea
BCNU
BiCNU
FIVB
N,N'-Bis(2-Chloroethyl)-N-Nitrosourea
Nitrumon
A cell-cycle phase nonspecific alkylating antineoplastic agent. It is used in the treatment of brain tumors and various other malignant neoplasms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p462) This substance may reasonably be anticipated to be a carcinogen according to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985). (From Merck Index, 11th ed)
- DUI
- D002330 MeSH Browser
- CUI
- M0003490
- CAS
- Urea, N,N'-bis(2-chloroethyl)-N-nitroso-
- Previous indexing
- Alkylating Agents (1966-1971); Nitroso Compounds (1966-1971); Urea (1966-1971)
- History note
- 73(72)
- Public note
- 73
Allowable subheadings
- AD
- administration & dosage 6
- AE
- adverse effects 3
- AG
- agonists
- AA
- analogs & derivatives
- AN
- analysis
- AI
- antagonists & inhibitors
- BL
- blood 1
- CF
- cerebrospinal fluid
- CS
- chemical synthesis
- CH
- chemistry
- CL
- classification
- EC
- economics 1
- HI
- history
- IM
- immunology
- IP
- isolation & purification
- ME
- metabolism
- PK
- pharmacokinetics
- PD
- pharmacology 1
- PO
- poisoning
- RE
- radiation effects
- ST
- standards
- SD
- supply & distribution
- TU
- therapeutic use 5
- TO
- toxicity
- UR
- urine
carmustine with prolifeprosan 20 Chemical MeSH Browser
carmustine, poliferprosan 20 drug combination Chemical MeSH Browser